Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Genomic profiling of combined hepatocellular‐cholangiocarcinoma reveals similar genetics to hepatocellular carcinoma
Nancy M. Joseph, Christos G. Tsokos, Sarah E. Umetsu, et al.
The Journal of Pathology (2019) Vol. 248, Iss. 2, pp. 164-178
Closed Access | Times Cited: 101

Showing 1-25 of 101 citing articles:

Tumour evolution in hepatocellular carcinoma
Amanda J. Craig, Johann von Felden, Teresa García‐Lezana, et al.
Nature Reviews Gastroenterology & Hepatology (2019) Vol. 17, Iss. 3, pp. 139-152
Closed Access | Times Cited: 681
Combined hepatocellular-cholangiocarcinoma: An update
Aurélie Beaufrère, Julien Caldéraro, Valérie Paradis
Journal of Hepatology (2021) Vol. 74, Iss. 5, pp. 1212-1224
Open Access | Times Cited: 148
Analysis of Liver Resection Versus Liver Transplantation on Outcome of Small Intrahepatic Cholangiocarcinoma and Combined Hepatocellular‐Cholangiocarcinoma in the Setting of Cirrhosis
Eléonora De Martin, M. Rayar, Nicolas Golse, et al.
Liver Transplantation (2020) Vol. 26, Iss. 6, pp. 785-798
Closed Access | Times Cited: 91
“Renal Cell Carcinoma With Leiomyomatous Stroma” Harbor Somatic Mutations of TSC1, TSC2, MTOR, and/or ELOC (TCEB1): Clinicopathologic and Molecular Characterization of 18 Sporadic Tumors Supports a Distinct Entity
Rajal B. Shah, Bradley A. Stohr, Zheng Jin Tu, et al.
The American Journal of Surgical Pathology (2019) Vol. 44, Iss. 5, pp. 571-581
Closed Access | Times Cited: 85
British Society of Gastroenterology guidelines for the diagnosis and management of cholangiocarcinoma
Simon Rushbrook, Timothy J. Kendall, Yoh Zen, et al.
Gut (2023) Vol. 73, Iss. 1, pp. 16-46
Open Access | Times Cited: 28
Tumor Mutational Burden for Predicting Prognosis and Therapy Outcome of Hepatocellular Carcinoma
Daniela Gabbia, Sara De Martin
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 3441-3441
Open Access | Times Cited: 23
Combined Hepatocellular Cholangiocarcinoma: A Population-Based Retrospective Study
Daryl Ramai, Andrew Ofosu, Jonathan Lai, et al.
The American Journal of Gastroenterology (2019) Vol. 114, Iss. 9, pp. 1496-1501
Closed Access | Times Cited: 58
Combined hepatocellular-cholangiocarcinoma: An update on epidemiology, classification, diagnosis and management
Dimitriοs Schizas, Aikaterini Mastoraki, Eleni Routsi, et al.
Hepatobiliary & pancreatic diseases international (2020) Vol. 19, Iss. 6, pp. 515-523
Closed Access | Times Cited: 54
The Diagnostic Approach towards Combined Hepatocellular-Cholangiocarcinoma—State of the Art and Future Perspectives
Johannes Eschrich, Zuzanna Kobus, Dominik Geisel, et al.
Cancers (2023) Vol. 15, Iss. 1, pp. 301-301
Open Access | Times Cited: 18
Progression of Low-Grade Neuroendocrine Tumors (NET) to High-Grade Neoplasms Harboring the NEC-Like Co-alteration of RB1 and TP53
Nancy M. Joseph, Sarah E. Umetsu, G. Kim, et al.
Endocrine Pathology (2024)
Open Access | Times Cited: 6
Hepatocellular carcinoma: making sense of morphological heterogeneity, growth patterns, and subtypes
Michael Torbenson
Human Pathology (2020) Vol. 112, pp. 86-101
Open Access | Times Cited: 47
Telomeres and Telomerase in the Development of Liver Cancer
Lena in der Stroth, Umesh Tharehalli, Çagatay Güneş, et al.
Cancers (2020) Vol. 12, Iss. 8, pp. 2048-2048
Open Access | Times Cited: 46
New insights into the pathophysiology and clinical care of rare primary liver cancers
Elia Gigante, Valérie Paradis, Maxime Ronot, et al.
JHEP Reports (2020) Vol. 3, Iss. 1, pp. 100174-100174
Open Access | Times Cited: 45
Molecular detection and clinicopathological characteristics of advanced/recurrent biliary tract carcinomas harboring the FGFR2 rearrangements: a prospective observational study (PRELUDE Study)
Yuta Maruki, Chigusa Morizane, Yasuhito Arai, et al.
Journal of Gastroenterology (2020) Vol. 56, Iss. 3, pp. 250-260
Open Access | Times Cited: 44
Updates in the diagnosis of combined hepatocellular-cholangiocarcinoma
Amedeo Sciarra, Young Nyun Park, Christine Sempoux
Human Pathology (2020) Vol. 96, pp. 48-55
Open Access | Times Cited: 42
Immune Profiling of Combined Hepatocellular- Cholangiocarcinoma Reveals Distinct Subtypes and Activation of Gene Signatures Predictive of Response to Immunotherapy
Công Trung Nguyễn, Stefano Caruso, Pascale Maillé, et al.
Clinical Cancer Research (2021) Vol. 28, Iss. 3, pp. 540-551
Open Access | Times Cited: 39
Pathologic and molecular features of hepatocellular carcinoma: An update
Mukul Vij, Julien Caldéraro
World Journal of Hepatology (2021) Vol. 13, Iss. 4, pp. 393-410
Open Access | Times Cited: 37
Potential Biomarkers for Liver Cancer Diagnosis Based on Multi-Omics Strategy
Fanghua Chen, Junming Wang, Yingcheng Wu, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 24
An mRNA expression-based signature for oncogene-induced replication-stress
Sergi Guerrero Llobet, Arkajyoti Bhattacharya, Marieke Everts, et al.
Oncogene (2022) Vol. 41, Iss. 8, pp. 1216-1224
Open Access | Times Cited: 23
Pathology of Combined Hepatocellular Carcinoma-Cholangiocarcinoma: An Update
Florian Roßner, Bruno V. Sinn, David Horst
Cancers (2023) Vol. 15, Iss. 2, pp. 494-494
Open Access | Times Cited: 16
Combined Hepatocellular-Cholangiocarcinoma: Biology, Diagnosis, and Management
Liangtao Ye, Julia S. Schneider, Najib Ben Khaled, et al.
Liver Cancer (2023) Vol. 13, Iss. 1, pp. 6-28
Open Access | Times Cited: 15
Mutational Landscape of Cholangiocarcinoma According to Different Etiologies: A Review
Simona Tavolari, Giovanni Brandi
Cells (2023) Vol. 12, Iss. 9, pp. 1216-1216
Open Access | Times Cited: 14
Intrahepatic cholangiocarcinoma: Morpho-molecular pathology, tumor reactive microenvironment, and malignant progression
Alphonse E. Sirica, Mario Strazzabosco, Massimiliano Cadamuro
Advances in cancer research (2020), pp. 321-387
Open Access | Times Cited: 37
The distribution of immune cells within combined hepatocellular carcinoma and cholangiocarcinoma predicts clinical outcome
Bohao Zheng, Jiaqiang Ma, Lingyu Tian, et al.
Clinical and Translational Medicine (2020) Vol. 10, Iss. 1, pp. 45-56
Open Access | Times Cited: 35
The immune microenvironment features and response to immunotherapy in EBV-associated lymphoepithelioma-like cholangiocarcinoma
Nai‐Jung Chiang, Ya‐Chin Hou, Kien Thiam Tan, et al.
Hepatology International (2022) Vol. 16, Iss. 5, pp. 1137-1149
Closed Access | Times Cited: 19
Page 1 - Next Page

Scroll to top